Metraipolis › archive › dc_f074e70474e8

De novo peptide design and experimental validation of histone methyltransferase inhibitors — Europe PMC PMID:24587223

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/24587223
DOI
10.1371/journal.pone.0090095
License (as archived)
solo-consultazione
Archived
2026-10-17T09:39:01.075Z
SHA-256 of the archived text
c5cdd65d662bb270573a4afce961401292c80f635cfe7de17e50444a4e44494b
Stable URL of this page
https://metraipolis.com/documento/dc_f074e70474e8

How to cite

De novo peptide design and experimental validation of histone methyltransferase inhibitors — Europe PMC PMID:24587223 — Europe PMC (en), https://europepmc.org/article/MED/24587223 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f074e70474e8 (Metraipolis archive dc_f074e70474e8, sha256 c5cdd65d662bb270573a4afce961401292c80f635cfe7de17e50444a4e44494b)
BibTeX
@misc{dcf074e70474e8,
  title = {De novo peptide design and experimental validation of histone methyltransferase inhibitors — Europe PMC PMID:24587223},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/24587223},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f074e70474e8; sha256 c5cdd65d662bb270573a4afce961401292c80f635cfe7de17e50444a4e44494b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/24587223. Agents can read the archived copy with the MCP tool read_document.